This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Hayashibara Co., Ltd., Kaisha Hayashibara Seibutsu Kagaku Kenkyujo. Active years: 1992-2014.
Company Filing History:
1 out of 47 
1 out of 1 Years Active: 1992-2014
Title: Ryuichi Motoda: Innovator in Human T-Cell Research
Introduction
Ryuichi Motoda is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of immunology, particularly in the development of human T-cell populations. With a total of 2 patents, his work focuses on enhancing our understanding of T-cell functions and their applications in medical science.
Latest Patents
Motoda's latest patents include groundbreaking inventions aimed at improving human health. One of his patents is centered around a novel human T-cell population that possesses both cytotoxic and immunosuppressive activities. This invention provides a method for preparing such a T-cell population by coculturing mononuclear cells from human blood with stroma cells. Another significant patent involves a process to prepare a metastasis-inhibitory factor (MIF) produced by human hematopoietic cells. This factor exhibits remarkable activity against viral diseases, immunopathies, and malignant tumors, showcasing the potential for therapeutic applications.
Career Highlights
Throughout his career, Ryuichi Motoda has worked with prominent companies such as Hayashibara Co., Ltd. and Kaisha Hayashibara Seibutsu Kagaku Kenkyujo. His experience in these organizations has contributed to his expertise in the field of immunology and cellular research.
Collaborations
Motoda has collaborated with esteemed colleagues, including Shuji Nakamura and Masayoshi Kibata. These partnerships have further enriched his research and innovation efforts.
Conclusion
Ryuichi Motoda's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and therapeutic applications.